As levels of obesity in the developed world continue to rise, advanced treatments for diabetes and cardiovascular disease are in constant demand. SMi's conference on Emerging Therapeutic Strategies for Metabolic Disorders will present the pharmaceutical industry with a review of recent developments along with insights into new avenues of research. The conference will take place in London.

Topics on the conference agenda include:

• Novel targets for the treatment of obesity and type II diabetes
• The therapeutic application of metabolic inhibitors
• DPP-4 inhibitors and GLP-1 receptor agonists
• Pharmacotherapy for obesity
• Immune therapy in type I diabetes
• New insulin sensitizer drugs

For more information on this conference please visit: www.smi-online.co.uk/metabolic2.asp